Chartwell Investment Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Chartwell Investment Partners’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,120	Closed	-$1.65M	–	453
2020 Q3	$1.65M	Hold	12,120	–	–	0.06%	294
2020 Q2	$1.17M	Sell	12,120 -788	-6%	-$65.7K	0.05%	317
2020 Q1	$605K	Buy	12,908 +1,392	+12%	+$89.2K	0.03%	356
2019 Q4	$839K	Buy	+11,516	New	+$699K	0.03%	365
2019 Q1	–	Sell	-29,521	Closed	-$1.44M	–	472
2018 Q4	$1.44M	Buy	29,521 +915	+3%	+$50.4K	0.05%	374
2018 Q3	$1.86M	Buy	28,606 +39	+0.1%	+$2.29K	0.05%	396
2018 Q2	$1.42M	Sell	28,567 -1,093	-4%	-$52.9K	0.04%	421
2018 Q1	$1.45M	Sell	29,660 -748	-2%	-$38.9K	0.05%	339
2017 Q4	$1.28M	Sell	30,408 -2,211	-7%	-$85.2K	0.04%	370
2017 Q3	$1.4M	Buy	+32,619	New	+$1.04M	0.05%	356

Chartwell Investment Partners's MYOK Position: Q4 2020 in Review

Chartwell Investment Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 12,120 shares — an estimated $1.65M sold.

Chartwell Investment Partners first reported a position in MYOK in Q3 2017 and held it in 10 quarters. The position peaked at $1.86M in Q3 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Chartwell Investment Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Chartwell Investment Partners sold 12,120 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.65M.
Chartwell Investment Partners first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 10 quarters.
Chartwell Investment Partners's MyoKardia, Inc. Common Stock position peaked at $1.86M in Q3 2018.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Chartwell Investment Partners's 13F filing for Q4 2020, filed 9 Feb 2021.